Nordhealth AS
Nordhealth AS is a healthcare equipment company that provides medical technology solutions, primarily generating revenue through the sale and service of diagnostic and therapeutic equipment.
Business. Nordhealth AS (NORDH.OL) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Norway and is listed on the Oslo Børs. Specific details regarding its operating segments and geographic revenue mix are not disclosed.
Analyst recommendations
1 analysts · consensus Buy- EarningsH1 2026 earnings (expected)2026-08-18 · estimated
- EarningsQ3 2026 earnings (expected)2026-11-10 · estimated
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsH1 2026 earnings (expected)2026-08-18 · estimated
- EarningsQ3 2026 earnings (expected)2026-11-10 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Nordhealth AS (NORDH.OL) is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is headquartered in Norway and is listed on the Oslo Børs. Specific details regarding its operating segments and geographic revenue mix are not disclosed.
Nordhealth AS has a strong liquidity position with a current ratio of 2.21, indicating the company can cover its short-term liabilities with its current assets. The company holds EUR 14.7 million in cash and equivalents, which is a significant portion of its total assets of EUR 71.5 million. However, the company's free cash flow is negative at EUR -6.5 million, driven by capital expenditures of EUR -5.1 million.
Profitability metrics show a challenging financial position for Nordhealth AS. The company reported a net loss of EUR -12.7 million and an operating loss of EUR -12.5 million in the latest period. Return on equity is negative at -20.6%, and return on assets is also negative at -17.7%. These figures are below the industry median for profitability metrics, indicating that Nordhealth AS is underperforming relative to its peers in the Advanced Medical Equipment & Technology industry.
Geographically, Nordhealth AS is primarily focused on the Nordic region, with a significant portion of its EUR 50.8 million in revenue derived from Norway. The company has limited international exposure, which could pose a concentration risk if the Norwegian market experiences economic downturns or regulatory changes.
Looking ahead, Nordhealth AS is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. The company's capital expenditures are expected to remain at current levels, and there are no immediate signs of aggressive expansion or contraction in the business.
The risk assessment for Nordhealth AS indicates a low level of liquidity risk, supported by its strong cash position and absence of long-term debt. However, the company's negative operating and net income raise concerns about its ability to sustain operations without external financing. The risk of dilution is also low, as there are no immediate filing-based flags indicating potential share dilution.
Recent events and filings for Nordhealth AS show a consistent financial position with no major changes in the company's capital structure or operations. The company has not issued new shares or taken on additional debt in the latest reporting period. Analysts have a strong buy rating for the stock, with a mean price target of EUR 33.00, suggesting confidence in the company's long-term prospects despite its current financial challenges.
- Nordhealth AS has a strong liquidity position with a current ratio of 2.21 and EUR 14.7 million in cash and equivalents.
- The company is currently unprofitable, with a net loss of EUR -12.7 million and a return on equity of -20.6%.
- Nordhealth AS is heavily concentrated in the Nordic region, particularly Norway, which could pose a concentration risk.
- Analysts have a strong buy rating for the stock, with a mean price target of EUR 33.00.
- The company has no immediate liquidity or dilution risks, but its negative operating and net income raise concerns about long-term sustainability.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,03 |
| Revenue | —no estimate | —no estimate | 57,2M EUR |
| Operating income | —no estimate | —no estimate | -8,7M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Nordhealth AS Market data — financials · 2026-05-28
- Nordhealth AS Market data — analyst estimates · 2026-05-28
Ownership & reference
Leadership
- Charles William MacbainCEO
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Return on equity (FY 2024-12-31): 0.3%Derived (calculated)
- Return on assets (FY 2024-12-31): 0.3%Derived (calculated)
- Current ratio (FY 2024-12-31): 9.40xDerived (calculated)
- Debt-to-equity (FY 2024-12-31): 0.00xDerived (calculated)
- Total assets (annual): NOK 3.16BBRREG filing
- Total equity & liabilities (annual): NOK 3.16BBRREG filing
- Net income (annual): NOK 8.37MBRREG filing
- Non current liabilities (annual): NOK 0BRREG filing
- Current liabilities (annual): NOK 3.19MBRREG filing
- Operating income (annual): NOK -6.14MBRREG filing
- Total liabilities (annual): NOK 3.19MBRREG filing
- Shareholders' equity (annual): NOK 3.16BBRREG filing
- Non current assets (annual): NOK 3.13BBRREG filing
- Total operating expenses (annual): NOK 6.14MBRREG filing
- Pre-tax income (annual): NOK 8.37MBRREG filing
- Current assets (annual): NOK 29.99MBRREG filing